Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21641362 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)
Condition: Actue Coronary Syndromes
Intervention: Drug: PRAVASTATIN SODIUM

Indicates status has not been verified in more than two years